Xu Cong Claire (CIK 2114309) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Buy NBP (9,382 shares), Sell NBP (3,282 shares), Buy NBP (12,432 shares), Sell NBP (4,485 shares), Buy NBP (9,382 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | NovaBridge Biosciences (NBP) | EVP, Clinical Development | Buy | 9,382 | $0 |
| 2026-09-01 | NovaBridge Biosciences (NBP) | EVP, Clinical Development | Sell | 3,282 | $2,593 |
| 2026-07-07 | NovaBridge Biosciences (NBP) | SVP, Clinical Development | Buy | 12,432 | $0 |
| 2026-07-07 | NovaBridge Biosciences (NBP) | SVP, Clinical Development | Sell | 4,485 | $3,992 |
| 2026-06-02 | NovaBridge Biosciences (NBP) | SVP, Clinical Development | Buy | 9,382 | $0 |
| 2026-06-02 | NovaBridge Biosciences (NBP) | SVP, Clinical Development | Sell | 3,494 | $13,766 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01